Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 16/20 | 0.62 |
| ▸ | PPARA | Q07869 | 9/20 | 0.62 |
| ▸ | PPARG | P37231 | 8/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KMO | O15229 | 3/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4025440 | 0.89 | PPARA (0.77) | PPARDPPARAPPARGKMO | |
| SCHEMBL13386559 | 0.88 | PPARD (0.55) | PPARDPPARAPPARGKMO | |
| Fonadelpar SCHEMBL1765984 | 0.87 | PPARD (0.81) | PPARDPPARAPPARG | |
| SCHEMBL4803451 | 0.87 | PPARD (0.59) | PPARDPPARAPPARGKMONR1H4 | |
| SCHEMBL4024977 | 0.86 | PPARD (0.54) | PPARDPPARAPPARGCYP3A4KMO | |
| SCHEMBL4034554 | 0.86 | PPARD (0.65) | PPARDPPARAPPARGKMO | |
| SCHEMBL4026350 | 0.85 | PPARD (0.54) | PPARDPPARAPPARGALDH1A1KMO | |
| SCHEMBL13386558 | 0.85 | PPARD (0.68) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL4033028 | 0.85 | PPARG (0.54) | PPARDPPARAPPARGCYP3A4ALOX15 | |
| SCHEMBL12732555 | 0.84 | PPARD (0.67) | PPARDPPARAPPARGKMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10709786-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2020-07-14 | — | — | US | claimed |
| EP-2952189-B1 | CLEAR AQUEOUS SOLUTION | SENJU PHARMA CO (JP) | 2019-09-18 | — | — | EP | claimed |
| US-20190255022-A1 | WOUND-HEALING AGENT | NIPPON CHEMIPHAR CO., LTD. (JP) | 2019-08-22 | — | — | US | claimed |
| EP-3456327-A1 | WOUND-HEALING AGENT | Nippon Chemiphar Co., Ltd. (JP) | 2019-03-20 | — | — | EP | claimed |
| US-20180177766-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-06-28 | — | — | US | claimed |
| US-9968679-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-05-15 | — | — | US | claimed |
| EP-3308784-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | Senju Pharmaceutical Co., Ltd. (JP) | 2018-04-18 | — | — | EP | claimed |
| EP-2952190-B1 | STABLE AQUEOUS SOLUTION | SENJU PHARMA CO (JP) | 2017-09-06 | — | — | EP | claimed |
| US-9463185-B2 | Pharmaceutical containing PPAR-delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2016-10-11 | — | — | US | claimed |
| US-20150366966-A1 | Stable Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | claimed |
| US-20150366969-A1 | Clear Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | claimed |
| EP-2952190-A1 | STABLE AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | claimed |
| EP-2952189-A1 | CLEAR AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | claimed |
| US-20140343109-A1 | PHARMACEUTICAL CONTAINING PPAR-delta AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | claimed |
| US-8802705-B2 | Pharmaceutical containing PPAR delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-08-12 | — | — | US | claimed |
| EP-2151438-B1 | PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST | SENJU PHARMA CO (JP) | 2012-10-31 | — | — | EP | claimed |
| US-20120270910-A2 | PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2012-10-25 | — | — | US | claimed |
| US-20100190833-A1 | PHARMACEUTICAL CONTAINING PPARA AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2010-07-29 | — | — | US | claimed |
| EP-2151438-A1 | PHARMACEUTICAL CONTAINING PPAR AGONIST | Senju Pharmaceutical Co., Ltd. (JP) | 2010-02-10 | — | — | EP | claimed |
| US-10709786-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2020-07-14 | — | — | US | disclosed |
| US-10709786-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2020-07-14 | — | — | US | disclosed |
| US-10426757-B2 | Compositions and methods for promoting intestinal stem cell and/or non-stem progenitor cell function | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2019-10-01 | — | — | US | disclosed |
| EP-2952189-B1 | CLEAR AQUEOUS SOLUTION | SENJU PHARMA CO (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-20190255022-A1 | WOUND-HEALING AGENT | NIPPON CHEMIPHAR CO., LTD. (JP) | 2019-08-22 | — | — | US | disclosed |
| EP-3456327-A1 | WOUND-HEALING AGENT | Nippon Chemiphar Co., Ltd. (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-20180177766-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-06-28 | — | — | US | disclosed |
| US-20180177766-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-06-28 | — | — | US | disclosed |
| US-9968679-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9968679-B2 | Clear aqueous solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2018-05-15 | — | — | US | disclosed |
| EP-3308784-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | Senju Pharmaceutical Co., Ltd. (JP) | 2018-04-18 | — | — | EP | disclosed |
| EP-3308784-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | Senju Pharmaceutical Co., Ltd. (JP) | 2018-04-18 | — | — | EP | disclosed |
| US-20170258772-A1 | COMPOSITIONS AND METHODS FOR PROMOTING INTESTINAL STEM CELL AND/OR NON-STEM PROGENITOR CELL FUNCTION | HOWARD HUGHES MEDICAL INSTITUTE | 2017-09-14 | — | — | US | disclosed |
| EP-2952190-B1 | STABLE AQUEOUS SOLUTION | SENJU PHARMA CO (JP) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016199871-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | 千寿製薬株式会社 | 2016-12-15 | — | — | WO | disclosed |
| US-9463185-B2 | Pharmaceutical containing PPAR-delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9463185-B2 | Pharmaceutical containing PPAR-delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20150366969-A1 | Clear Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| US-20150366966-A1 | Stable Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| US-20150366969-A1 | Clear Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| US-20150366966-A1 | Stable Aqueous Solution | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-2952190-A1 | STABLE AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952189-A1 | CLEAR AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952190-A1 | STABLE AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952189-A1 | CLEAR AQUEOUS SOLUTION | Senju Pharmaceutical Co., Ltd. (JP) | 2015-12-09 | — | — | EP | disclosed |
| CN-105025896-A | Clear aqueous liquid formulations | SENJU PHARMA CO | 2015-11-04 | — | — | CN | disclosed |
| CN-105007918-A | Stable aqueous liquid preparation | SENJU PHARMA CO | 2015-10-28 | — | — | CN | disclosed |
| US-20140343109-A1 | PHARMACEUTICAL CONTAINING PPAR-delta AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140343109-A1 | PHARMACEUTICAL CONTAINING PPAR-delta AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-8802705-B2 | Pharmaceutical containing PPAR delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8802705-B2 | Pharmaceutical containing PPAR delta agonist | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2014-08-12 | — | — | US | disclosed |
| WO-2014119642-A1 | STABLE AQUEOUS SOLUTION | 千寿製薬株式会社 (JP) | 2014-08-07 | — | — | WO | disclosed |
| WO-2014119643-A1 | CLEAR AQUEOUS SOLUTION | 千寿製薬株式会社 (JP) | 2014-08-07 | — | — | WO | disclosed |
| CN-101801941-B | Pharmaceutical containing ppar delta agonist | NIPPONCHEMIPHAR CO LTD | 2012-12-12 | — | — | CN | disclosed |
| EP-2151438-B1 | PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST | SENJU PHARMA CO (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20120270910-A2 | PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2012-10-25 | — | — | US | disclosed |
| CN-101801941-A | Pharmaceutical containing ppar delta agonist | SENJU PHARMA CO | 2010-08-11 | — | — | CN | disclosed |
| US-20100190833-A1 | PHARMACEUTICAL CONTAINING PPARA AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| US-20100190833-A1 | PHARMACEUTICAL CONTAINING PPARA AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2151438-A1 | PHARMACEUTICAL CONTAINING PPAR AGONIST | Senju Pharmaceutical Co., Ltd. (JP) | 2010-02-10 | — | — | EP | disclosed |
| EP-2151438-A1 | PHARMACEUTICAL CONTAINING PPAR AGONIST | Senju Pharmaceutical Co., Ltd. (JP) | 2010-02-10 | — | — | EP | disclosed |
| EP-1445258-B1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA | NIPPON CHEMIPHAR CO (JP) | 2009-06-24 | — | — | EP | disclosed |
| WO-2008143254-A1 | PHARMACEUTICAL CONTAINING PPARΔ AGONIST | SENJU PHARMACEUTICAL CO., LTD. (JP) | 2008-11-27 | — | — | WO | disclosed |
| US-7402597-B2 | Activator of peroxisome proliferator-activated receptor δ | NIPPON CHEMIPHAR CO., LTD (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20070027196-A1 | Activator of peroxisome proliferator-activated receptor delta | SAKUMA SHOGO | 2007-02-01 | — | — | US | disclosed |
| US-7119104-B2 | Activator of peroxisome proliferator-activated receptor delta | NIPPON CHEMIPHAR, CO., LTD. (JP) | 2006-10-10 | — | — | US | disclosed |
| US-20050096363-A1 | Activator of peroxisome proliferator-activated receptor delta | NIPPON CHEMIPHAR CO., LTD. (JP) | 2005-05-05 | — | — | US | disclosed |
| EP-1445258-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA | NIPPON CHEMIPHAR CO., LTD. (JP) | 2004-08-11 | — | — | EP | disclosed |
| EP-1445258-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA | NIPPON CHEMIPHAR CO., LTD. (JP) | 2004-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190255022-A1 | WOUND-HEALING AGENT | PPARG, PPARA, PPARD | PPARD 3/4885PPARA 2/4885PPARG 1/4885 |
| US-10426757-B2 | Compositions and methods for promoting intestinal stem cell and/or non-stem progenitor cell function | FABP2, ALPG, ALPI | PPARD 2842/4885PPARA 1257/4885PPARG 786/4885 |
| US-20180177766-A1 | THERAPEUTIC AGENT FOR NEUROTROPHIC KERATOPATHY | NTRK2, BDNF, PPARA | PPARD 4/4885PPARA 3/4885PPARG 5/4885 |
| US-20070027196-A1 | Activator of peroxisome proliferator-activated receptor delta | PPARA, PPARG, PPARD | PPARD 3/4885PPARA 1/4885PPARG 2/4885 |
| US-20120270910-A2 | PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST | PPARA, PPARD, PPARG | PPARD 2/4885PPARA 1/4885PPARG 3/4885 |
| US-20170258772-A1 | COMPOSITIONS AND METHODS FOR PROMOTING INTESTINAL STEM CELL AND/OR NON-STEM PROGENITOR CELL FUNCTION | FABP2, ALPG, ALPI | PPARD 2842/4885PPARA 1257/4885PPARG 786/4885 |
| US-20150366966-A1 | Stable Aqueous Solution | CEL, TBCA, LIPA | PPARD 564/4885PPARA 94/4885PPARG 292/4885 |
| US-20140343109-A1 | PHARMACEUTICAL CONTAINING PPAR-delta AGONIST | PPARA, PPARD, PPARG | PPARD 2/4885PPARA 1/4885PPARG 3/4885 |
| US-20050096363-A1 | Activator of peroxisome proliferator-activated receptor delta | PPARA, PPARG, PPARD | PPARD 3/4885PPARA 1/4885PPARG 2/4885 |
| US-20100190833-A1 | PHARMACEUTICAL CONTAINING PPARA AGONIST | PPARA, PPARD, PPARG | PPARD 2/4885PPARA 1/4885PPARG 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.